...
首页> 外文期刊>Lab on a chip >Development of a high-throughput arrayed neural circuitry platform using human induced neurons for drug screening applications
【24h】

Development of a high-throughput arrayed neural circuitry platform using human induced neurons for drug screening applications

机译:利用人诱导的药物筛查应用开发高吞吐量的神经电路平台

获取原文
获取原文并翻译 | 示例

摘要

Proper brain function relies on the precise arrangement and flow of information between diverse neural subtypes. Developing improved human cell-based models which faithfully mimic biologically relevant connectivity patterns may improve drug screening efforts given the limited success of animal models to predict safety and efficacy of therapeutics in human clinical trials. To address this need, we have developed experimental models of defined neural circuitries through the compartmentalization of neuronal cell subtypes in a 96 well plate-based platform where each microwell is divided into two compartments connected by microchannels allowing high-throughput screening (HTS) of small molecules. We demonstrate that we can generate subtype-specific excitatory and inhibitory induced neuronal cells (iNs) from human stem cell lines and that these neurons form robust functional circuits with defined connectivity. Through the use of the genetically encoded calcium indicator GCaMP6f, we monitor calcium ion transients generated during neuronal firing between and within compartments. We further demonstrate functionality of the circuit by perturbing network activity through the addition of glutamate receptor blockers using automated liquid handling. Lastly, we show that we can stimulate network activity in defined neuronal subtypes through the expression of the designer receptor exclusively activated by designer drugs (DREADD) hM3Dq and application of the ligand clozapine-N-oxide (CNO). Our results demonstrate the formation of functional neural circuits in a high-throughput platform that is compatible with compound screening, representing an important step towards developing new screening platforms for studying and ultimately treating psychiatric brain disorders that arise from disordered neural circuit function.
机译:适当的脑功能依赖于不同神经亚型之间的精确布置和信息流动。制定改进的基于人的细胞基础型模型,忠实地模仿生物学相关的连接模式可以改善药物筛查努力,鉴于动物模型的成功有限,以预测治疗剂在人类临床试验中的安全性和有效性。为了解决这种需求,我们通过在基于96个井板的平台中的神经元细胞亚型的划分结构开发了定义神经电路的实验模型,其中每个微孔被分成由微通道连接的两个隔室,允许高通量筛选(HTS)小分子。我们证明我们可以从人干细胞系产生亚型特异性兴奋性和抑制性神经元细胞(INS),并且这些神经元形成具有限定的连接的鲁棒功能性电路。通过使用遗传编码的钙指示器Gcamp6F,我们监测在隔室之间和内部的神经元烧制期间产生的钙离子瞬变。我们进一步通过使用自动液体处理通过添加谷氨酸受体阻挡剂来证明通过扰动网络活性的电路的功能。最后,我们表明我们可以通过设计者药物(DREADD)HM3DQ(DRADD)HM3DQ(DNO)的应用,通过专门激活的设计者受体的表达刺激定义的神经元亚型中的网络活性。我们的结果表明,在与复合筛选兼容的高通量平台中的功能神经电路的形成,代表了开发新的筛选平台,用于研究和最终治疗来自无序神经电路功能的精神脑疾病的重要措施。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号